Stockwinners Market Radar for November 19, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:01 EDT Alibaba, Auchan Retail, Ruentex form new retail strategic alliance - Alibaba, Auchan Retail and Ruentex have announced a strategic alliance that brings together their online and offline expertise to explore new retail opportunities in China's food retail sector. As part of this strategic alliance, Alibaba will invest a total of $2.88B to obtain an aggregate direct and indirect stake of 36.16% in Sun Art Retail Group by acquiring shares from Ruentex. Auchan Retail is also increasing its stake in Sun Art. The transaction will give Auchan Retail, Alibaba Group and Ruentex approximately a 36.18%, 36.16%, and 4.67% economic interest in Sun Art, respectively. Auchan Retail will continue to consolidate Sun Art in its financials following the transaction. Sun Art is a multi-format offline food retailer in China. As of June 30, 2017, Sun Art operated with a total gross floor area of approximately 12M square meters in China. Sun Art currently operates 446 hypermarkets as large as 17,000 square meters in 29 provinces, autonomous regions and municipalities across China under the "RT-Mart" and "Auchan" banners. It also operates superstores and innovative unmanned stores under the "Auchan Minute" brand. Combining the resources of the three companies, the new alliance will enable Sun Art's activities to benefit from Alibaba's digital ecosystem. It will digitize and introduce new retail solutions at Sun Art stores, including online and offline integration together with modern fulfillment and personalized customer experience.

17:01 EDT Galapagos NV reports positive topline results from ALBATROSS with GLPG2222 - Galapagos NV reports positive topline results from its ALBATROSS Phase 2 study in cystic fibrosis patients with C1 corrector GLPG2222. The ALBATROSS study included 37 cystic fibrosis patients with a gating mutation on one allele and F508del mutation on the other allele. All patients were on long-term stable Kalydeco treatment at screening and continued their Kalydeco treatment throughout the study. The ALBATROSS study was fully recruited within five months. Primary objectives of this randomized, double-blinded, placebo controlled study were to evaluate the safety and tolerability and pharmacokinetics of novel C1 corrector GLPG2222 in this CF patient population. Once daily doses of 150mg GLPG2222, 300mg GLPG2222 or placebo were administered. Overall, GLPG2222 was well tolerated, with observed treatment emergent adverse events being predominantly mild or moderate, and typical for a CF patient population. There were no serious adverse events reported and no discontinuations due to adverse events. The targeted exposures of GLPG2222 were achieved in this patient study, further strengthening dosing modelling for the first investigational triple combination. Exposures achieved in patients were in line with those observed in healthy volunteers. The additional activity observed with treatment with GLPG2222 on top of Kalydeco was in line with what was observed with tezacaftor combined with Kalydeco in a Phase 2 study in this population. A statistically significant dose dependent decrease in sweat chloride concentration was observed amounting to a decrease of 6 mmol/L in the 300mg cohort. Mean percent predicted FEV1 levels overall were 70% at screening. At the end of treatment with 300mg GLPG2222, ppFEV1 levels increased by 2.2%.

16:22 EDT Bombardier predicts Latin America's 60-150 seat aircraft fleet will double - Bombardier Commercial Aircraft's Market Forecast 2017-2036 for Latin America predicts that overall traffic is expected to grow 5.1% annually and intra-regional traffic to grow slightly more than the world average at 5.6% annually over the next 20 years. Total deliveries in the 60- to 150-seat marked segment to Latin America are expected to number 1,050 aircraft, or 8% of total world deliveries of 12,550 aircraft. Latin America deliveries will consist of 500 large regional aircraft and 550 small single-aisle aircraft, which will double the size of the current fleet. Bombardier market forecasts identifies that approximately 450 regional routes have been dropped in the past ten years. This represents about 16M potential passengers per year that are not being served with direct flights. Compared to other similar regions, Latin America would need approximately 2,600 intraregional routes instead of the current 1,700 markets with regular scheduled service. That creates a great opportunity to stimulate its connectivity.